Abstract: Global 3D Cell Culture Market to Reach US$2. 4 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for 3D Cell Culture estimated at US$972.

New York, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global 3D Cell Culture Industry" - https://www.reportlinker.com/p05797741/?utm_source=GNW 1 Million in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at a CAGR of 13.7% over the analysis period 2020-2027.Scaffold-based, one of the segments analyzed in the report, is projected to grow at a 13.9% CAGR to reach US$1.1 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Scaffold-free segment is readjusted to a revised 13.1% CAGR for the next 7-year period. This segment currently accounts for a 27.2% share of the global 3D Cell Culture market.

The U.S. Accounts for Over 35.1% of Global Market Size in 2020, While China is Forecast to Grow at a 14.8% CAGR for the Period of 2020-2027

The 3D Cell Culture market in the U.S. is estimated at US$341.2 Million in the year 2020. The country currently accounts for a 35.1% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$161.4 Million in the year 2027 trailing a CAGR of 14.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.3% and 11.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR while Rest of European market (as defined in the study) will reach US$161.4 Million by the year 2027.

Microfluidics-based Segment Corners a 17.1% Share in 2020

In the global Microfluidics-based segment, USA, Canada, Japan, China and Europe will drive the 15.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$139.1 Million in the year 2020 will reach a projected size of US$377.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$186.4 Million by the year 2027.

Select Competitors (Total 38 Featured)

Story continues

3D Biotek, LLC

Advanced Biomatrix, Inc.

Becton Dickinson and Company

Corning Inc.

Greiner Bio One International GmbH

Hamilton Company

InSphero AG

Lonza Group AG

Merck KGaA

Mimetas B.V.

Nanofiber Solutions

REPROCELL USA Inc.

Synthecon, Incorporated

Tecan Trading AG

Thermo Fisher Scientific Inc.

Read the full report: https://www.reportlinker.com/p05797741/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession 3D Cell Culture Transforms Life Sciences Industry 3D Cell Culture: An Introduction 3D-Cell Culture Models Benefits of 3D Cell Culture Key 3D Cell Culture Formats 3D Cell Culture?Different Techniques Scaffold-Based 3D Cell Culture Polymeric Hard Scaffolds Biological Scaffolds Micropatterned Surface Microplates Non-Scaffold Based 3D Cell Culture Hanging Drop Microplates Spheroid Microplates with Ultra-Low Attachment (ULA) coating Microfluidic 3D Cell Culture Expanding Applications Fuel Growth in the Global 3D Cell Culture Market Developed Regions Lead the 3D Cell Culture Market, Asia-Pacific to Register Faster Growth Scaffold-based 3D Cell Culture Products Dominate the Market Cancer and Stem Cell Research Leads the Global Market Competitive Scenario Key Commercial 3D Cell Culture Devices

2. FOCUS ON SELECT PLAYERS Recent Market Activity

3. MARKET TRENDS & DRIVERS Rising Incidence of Cancer Drives the Demand for 3D Cell Culture EXHIBIT 1: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 EXHIBIT 2: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018 EXHIBIT 3: Number of New Cancer Cases and Deaths (in Million) by Region for 2018 Increasing Demand for 3D Cell Culture in Drug Discovery Use of 3D Cell Culture for Regenerative Medicine Organoids as Alternatives to Using Animals in Experiments Use of 3D Cell Culture for Regenerative Medicine Microfluidic Chips Hold Potential in Addressing 3D Cell Culture Challenges Technological Advancements Promote 3D Cell Culture Market Researchers Use Lab-on-a-CD Technology to Generate Spheroid 3D Cell Cultures 3D Bioprinting Holds Potential to Revolutionize Organ Transplantation Space A Review of Research Efforts and Achievements of Companies and Universities 3D Tissue Culture: Growing Significance in Cancer Research Cells Grown in 3D Change Cell Proliferation and Morphology Cells Grown in 3D Demonstrate a More Pragmatic Drug Response Cells Grown in 3D Express Phenotypic Heterogeneity Cells Grown in 3D Alter Cell Behavior and Gene Expression Cells Grown in 3D Replicate the Tumor Microenvironment Other Advantages of 3D Tissue Culture Models New Dimension of Cell Culture: The Rise of Spheroid Culture Systems Challenges Progress in Scaffolds and Hydrogels Aids Creation of Organoids and Spheroids

4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 3: World 10-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2017, 2020 & 2027

Table 4: World Current & Future Analysis for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 6: World 10-Year Perspective for Scaffold-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027

Table 7: World Current & Future Analysis for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 9: World 10-Year Perspective for Scaffold-free by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027

Table 10: World Current & Future Analysis for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 12: World 10-Year Perspective for Microfluidics-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027

Table 13: World Current & Future Analysis for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 15: World 10-Year Perspective for Magnetic & Bioprinted by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027

Table 16: World Current & Future Analysis for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 18: World 10-Year Perspective for Cancer & Stem Cell Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027

Table 19: World Current & Future Analysis for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 21: World 10-Year Perspective for Drug Discovery & Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027

Table 22: World Current & Future Analysis for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 24: World 10-Year Perspective for Tissue Engineering & Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES Table 25: USA Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 27: USA 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027

Table 28: USA Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 30: USA 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027

CANADA Table 31: Canada Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 32: Canada Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 33: Canada 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027

Table 34: Canada Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 36: Canada 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027

JAPAN Table 37: Japan Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 38: Japan Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 39: Japan 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027

Table 40: Japan Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 42: Japan 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027

CHINA Table 43: China Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 44: China Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 45: China 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027

Table 46: China Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 47: China Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 48: China 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027

EUROPE Table 49: Europe Current & Future Analysis for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 50: Europe Historic Review for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 51: Europe 10-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2017, 2020 & 2027

Table 52: Europe Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 54: Europe 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027

Table 55: Europe Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 56: Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 57: Europe 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027

FRANCE Table 58: France Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 59: France Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 60: France 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027

Table 61: France Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 62: France Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 63: France 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027

GERMANY Table 64: Germany Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 65: Germany Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 66: Germany 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027

Table 67: Germany Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 68: Germany Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR

Table 69: Germany 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027

ITALY Table 70: Italy Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

See more here:

Global 3D Cell Culture Market to Reach US$2.4 Billion by the Year 2027 - Yahoo Finance

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh